Near-infrared spectroscopy (NIRS) has been employed to assess the composition of the atherosclerotic plaques in native coronary arteries. However, little is known about the detection of neoatherosclerosis by NIRS in in-stent restenosis (ISR). The aim of the study was to assess the relationship between the distribution of lipid determined by NIRS and morphology of ISR on optical coherence tomography (OCT).
Introduction
Similar to de novo atherosclerosis in native coronary arteries, neointima overlying stent struts can become lipid laden over time and develop into neoatherosclerosis (NA). These newly formed atherosclerotic plaques may lead to late stent failure. 1 -5 Analogous to vulnerable plaques in native coronaries, neoatheromatous plaques that are prone to rupture also have a thin fibrous cap covering the lipid core (,65 mm). 4 -7 Therefore, the detection of the thin fibrous cap neoatheromas (TCNA) may help to identify patients with higher risk of late stent failure. Optical coherence tomography (OCT) provides high-resolution images (10 -20 mm) that enable measurement of the thickness of the fibrous cap covering the lipid core, a validated measure of plaque vulnerability. 6 Moreover, OCT discerns between fibrous, calcified, and lipid components of the plaque with high sensitivity and specificity. 8 However, OCT imaging requires clearance of blood from the vessel by injection of flush media, which limits its use in situations such as renal dysfunction. This limitation of OCT may be overcome with the use of intravascular ultrasound (IVUS). However, the resolution of the greyscale IVUS is below 100 mm and, as such, measurement of cap thickness with the required accuracy for the detection of TCNA is not feasible with this imaging modality 9 and is further compounded by limited assessment of plaque composition on IVUS other than presence of calcification.
Recently, near-infrared spectroscopy (NIRS) has been developed to assess the composition of atherosclerotic plaques in native coronary arteries by distinguishing between lipid and non-lipid components as well as some characteristics suggestive of plaque vulnerability. 10 -12 Although considerable focus has been put on the utility of NIRS to detect vulnerable plaques in native coronary arteries and, more recently, its potential role in detecting lipid-rich plaques within stented segments to identify neoatherosclerosis, 13 the ability of NIRS to detect TCNA has not been studied. In the present study, we examined the relationship between distribution of lipid assessed by NIRS and OCT in in-stent restenosis (ISR) and the ability of NIRS to detect TCNA in a head-to-head comparison with OCT.
Methodology Study population
The current study employed intravascular NIRS/IVUS and OCT to assess ISR in the same stented segment of the coronary artery in patients undergoing elective coronary intervention because of ISR. Patients with renal failure (creatinine level .1.5), haemodynamic compromise, contrast allergy, and aorto-ostial coronary lesions were excluded. NIRS/ IVUS and OCT imaging were performed after the intracoronary administration of nitroglycerine (100 -200 mg). No complications occurred due to performance of these two imaging modalities. OCT and NIRS/ IVUS results were combined into one database together with the results of the quantitative coronary arteriography (QCA).
The study was performed in accordance with Code of Federal Regulations and Declaration of Helsinki. All participants in the study signed an informed consent before the procedure.
QCA measurements
QCA was performed using a validated cardiovascular measurement system (Q MEDIS, AngioXA software 7.3 version, Leiden, The Netherlands) for calculation of the reference diameter, the minimum lumen diameter, and the percent diameter stenosis.
Image acquisition by OCT
The intravascular OCT was performed with the commercially available OCT C7 Dragonfly TM or Optis catheter (St Jude Medical, Minneapolis, MN, USA). The tip of the OCT lens was placed 10 mm distal to the distal edge of the stent as the starting point of the pullback. Appropriate OCT image acquisition required continuous intracoronary injection of 12 -16 mL of contrast at a speed of 3 -4 mL/s followed by the pullback of the catheter (20 mm/s). The single pullback of the OCT catheter scanned 54 -75 mm of the coronary artery.
OCT analysis
The total length of the stented artery was examined per mm segments on OCT at an axial slice thickness of 20 mm using proprietary software (St Jude Medical). The composition of the neointima was analysed according to the previously validated criteria for OCT. 8 In brief, a signalrich homogeneous neointima was identified as fibrous, signal-poor regions with diffuse borders as lipid and signal-poor regions with well-defined borders as calcified plaques. The amount of lipid in the neointima was measured by the transverse extent of lipid in crosssectional images (OCT lipid arc, 8) and by the length (mm). OCT lipid-rich plaque was defined as lipid arc .908. Three separate measurements were performed at the thinnest part of the fibrous cap covering the lipid core, and the average value was defined as the fibrous cap thickness on OCT. OCT-derived TCNA was defined as a lipid core covered with fibrous cap thickness ,65 mm. Additionally, the presence of plaque rupture and thrombus formation were also recorded during analysis. Cross-sectional area (CSA) of the lumen and the stent were measured every mm, and the CSA of neointima was calculated by subtracting the lumen CSA from the stent CSA. The neointima burden was defined as the CSA of neointima divided by stent CSA and expressed as percentage.
Image acquisition by NIRS
The total length of the stented artery was examined per mm segments using TVC NIRS/IVUS at an axial slice thickness of 400 mm using proprietary software (Infraredx, Burlington, MA, USA). Similar to OCT catheter, the NIRS/IVUS probe was positioned 10 mm distal to the stent. Automated pullback was started at a speed of 0.5 mm/s with 80 spectroscopic measurements performed per minute.
Analysis of NIRS data
NIRS estimates the distribution of lipids within the arterial wall and presents the data as red or yellow on the NIRS map and block chemogram, with yellow indicating the presence of lipid and red the absence of lipid ( Figure 1 ). The NIRS map allows for calculation of LCBI, a measure of total lipid burden (¼total yellow pixel/total viable pixel within the region of interest × 1000). In the present study, LCBI was calculated for every 2 mm (LCBI 2mm ) and 4 mm (LCBI 4mm ) segments within the stent. Moreover, similar to OCT, the NIRS map allowed for evaluation of the transverse and the longitudinal extent of lipid (NIRS lipid arc and lipid length, respectively). We identified lipid-rich neointima on NIRS when the block chemogram presented yellow pixels within a 2 mm segment in the stent. On post hoc analysis of the block chemogram, the LCBI for the selected segments of the stent was calculated by the Lipiscan LS107.001rB software (InfraRedX) and lipid arc and lipid length on NIRS were estimated using the ImageJ software ( Figure 1 ).
Comparison of NIRS with OCT
During the pullback of the NIRS/IVUS catheter, anatomical landmarks were imprinted-i.e. the proximal and the distal edge of the stent and ostia of side branches. These landmarks allowed matching of the NIRS map and the block chemogram to corresponding OCT cross-sectional images ( Figure 1) . To compare the distribution of lipid on NIRS to OCT, we analysed the maximal lipid arc and lipid length detected by the two imaging modalities. In addition, we assessed the correlation between LCBI value on NIRS and the minimal cap thickness of the lipid-rich neointima on OCT.
Statistical analysis
Data analysis was performed using Medcalc software version 12.2.1 (Ostend, Belgium). The data were assessed by Komolgov -Smirnov for normality. The normally distributed data were presented as mean with standard deviation (SD) and otherwise as median with 1st and 3rd quartiles. Statistical comparisons were made using Pearson's correlation and unpaired t-test in normally distributed data and Spearman's rank correlation and Mann-Whitney test for non-normally distributed data. Categorical data were compared using x 2 test. A two-tailed P-value of ,0.05 was considered statistically significant. The univariate binary logistic regression was performed to estimate the ability of parameters on NIRS to predict TCNA identified on OCT, with ROC analysis of the LCBI values vs. presence or absence of TCNA on OCT utilized to assess accuracy. The diagnostic efficiency of the variables was classified according to the values of area under the curve (AUC) and defined as low (,0.70), moderate (0.70-0.90), and high (.0.9). The criterion values for NIRS and IVUS measurements were estimated by the method proposed by Zweig and Campbell 14 and were expressed with associated sensitivity, specificity, and positive and negative predictive values. The intra-class correlation coefficients were measured to estimate the inter-observer variability in analysis of the OCT images. The inter-rater agreement (kappa) was calculated to present the inter-observer variability for identification of TCNA on OCT and to compare NIRS and OCT for identification of lipid-rich neoinitma within the stent.
Results
We analysed 39 DES in 36 patients. OCT detected lipid-rich neointima in 27 stents (69%), while lipid-rich neointima was detected in 24 stents (61%) on NIRS. Twenty-two in-stent neointimal lesions (56%) were identified as lipid-rich by both NIRS and OCT. There were no differences in the clinical characteristics (Table 1) or type, location, diameter, or length of stents in patients with and without OCT-defined TCNA ( Table 2) . However, stents with TCNA had smaller reference diameters compared with stents without TCNA. Furthermore, NIRS and OCT analysis demonstrated that stents with OCT-derived TCNA had both greater lipid arc and lipid length ( Table 3) . Lastly, maximal LCBI 2mm and maximal LCBI 4mm were also higher for stents with OCT-defined TCNA ( Table 3) .
Correlation of NIRS and OCT in early and late ISR
The early ISR (,12 months after implantation) occurred in 9 (23%) stents at a median of 7 months (IQR 3 -10), and late ISR (.12 months after implantation) was detected in 30 stents at a median of 50 months (IQR 29 -65). OCT detected lipids in 6 (66%) early ISR at 5 months (IQR 3-10) and in 21 (70%) late ISR at 50 months (IQR 32-66) (P ¼ 0.82). NIRS detected lipids in 3 (33%) early ISR at 10 months (IQR 3-11) and in 21 (70%) late ISR at 50 months, (IQR 32 -64) (P ¼ 0.11). OCT-defined TCNA was detected in 1 (11%) early ISR at 1 month and in 11 (36%) late ISR at 50 months (IQR 33 -67) (P ¼ 0.29). The inter-modality agreement was fair in early ISR (kappa ¼ 0.40, 95% CI: 20.04 to 0.84) but very good in late ISR (kappa ¼ 0.68, 95% CI: 0.39-0.96).
Detection of OCT-defined TCNA on NIRS
The minimal thickness of fibrous caps in in-stent neoatherosclerotic plaques measured by OCT correlated both with maximal LCBI 2mm (r ¼ 20.74, P , 0.001) and maximal LCBI 4mm (r ¼ 20.78, P,0.001) (Figure 2) . Univariate binary logistic regression analysis revealed that both maximal LCBI 2mm (OR ¼ 2.21, 95% CI: 1.44-3.40; P , 0.001) and maximal LCBI 4mm (OR ¼ 2.34, 95% CI: 1.48-3.72; P , 0.001) were predictors of OCT-defined TCNA. Moreover, Receiver operating characteristic curve analysis revealed high accuracy for maximal LCBI 2mm and maximal LCBI 4mm to detect TCNA identified by OCT. The highest sensitivity, specificity, and positive and negative predictive values were estimated for maximal LCBI 2mm .163 and maximal LCBI 4mm .144 (Figure 2 OCT 928 (IQR 0 -187), P ¼ 0.825); however, lipid length was longer on NIRS than on OCT (11 mm (IQR 6-15) vs. 4 mm (IQR 0-11), P , 0.001).
Inter-observer variability for OCT analysis
The intra-class correlation coefficients for single measurements 
Discussion
Previous autopsy studies have validated NIRS for the detection of lipid in atherosclerotic plaques, 11 and NIRS has been suggested to be able to detect traits suggestive of plaque vulnerability. 15 This concept has been supported not only by experimental studies but also by clinical observations. 7 Coronary lesions causing acute coronary syndromes (ACSs) are characterized by greater lipid core when compared with lesions in stable coronary artery disease. 16 However, these previous reports did not examine the utility of NIRS to detect lipid in plaques within the stented segments, an important attribute given the increasing recognition of neoatherosclerosis as a primary cause of late stent failure. In the present study, we assessed NIRS-and OCT-derived distribution of lipid within neointimal tissue and report a number of important comparisons. First, we show that NIRS can detect potentially vulnerable neoatherosclerotic plaques defined by OCT with high accuracy. Lipid-rich neointima was detected in 56% of stents by both OCT and NIRS with good intermodality agreement. Secondly, we report that NIRS can accurately detect TCNA identified by OCT in 92% of cases with the cut-off value for LCBI 2mm .163 and LCBI 4mm .144, with the accuracy exceeding that of virtual histology-IVUS (VH-IVUS) (78%). 6 Lastly,
we identified an inverse relationship between lipid-core burden and cap thickness within the stent. These results are consistent with previous VH-IVUS and OCT findings 6 and complement our previous report. 7 However, the present study showed that while the inter-modality agreement in lipid detection between OCT and NIRS was very good in late ISR, it was just fair in early ISR, indicating that care should be taken for the detection of TCNA by NIRS alone in early ISR and OCT imaging should be considered as an adjunct to increase accuracy. Our results suggest NIRS can potentially detect vulnerable plaques in neoatherosclerotic tissue. The detection of such high-risk features may help in identifying patients prone to late loss or very late stent thrombosis as a result of TCNA rupture, but also guide ISR treatment. In a separate cohort of patients, we showed previously that peri-procedural myocardial infarction occurred exclusively in patients with evidence of in-stent lipid [median LCBI 4mm 113 (IQR 68, 227)] with a trend towards increased frequency with the use of cutting balloon pre-dilation. 7 As such, the detection of lipid in neointima may aid in guiding the use of devices such as cutting balloons, scoring balloons, or atherectomy in the treatment of ISR. Furthermore, it may also help in identifying patients who require more aggressive lipid lowering in addition to the treatment of ISR by PCI. Aggressive lipid-lowering therapy has been reported to increase fibrous components of plaque in both native arteries 17 and ISR. 18 It is notable that the thresholds for LCBI (LCBI 2mm .163/ LCBI 4mm .144) to detect TCNA are lower than the threshold that predicts peri-procedural MI in native coronary arteries (as reported in the Color Registry and Canary trial). 19, 20 However, these values are in agreement with our previous report and validate our classification of neoatherosclerosis on OCT. 7 The lower LCBI va- Utility of NIRS for detection of TCNA nidus for lipid deposition and as such the pathophysiological mechanisms for the development of TCNA may be less related to overall plaque burden as it is in native coronary arteries 21 and is likely related to spatial localization of lumen-centric lipid deposition as we have described. 7 Although there was a strong correlation between quantitative analyses of lipid by NIRS and OCT, some discrepancies were indeed observed. NIRS did not detect lipid-rich neointimal plaques that were identified by OCT in five stented vessels. This difference may be attributable to signal attenuation, classically associated with lipidaemic plaque, but also found in other scenarios such as macrophage accumulation, 4 granulation tissue, 22 -24 and vessel tortuosity. 25 Conversely, NIRS detected lipid in two stented segments that were not detected by OCT. In these cases, it is likely that the lipidaemic plaques were pre-existing fibroatheromas that were remote from the lumen. While IVUS was unable to confirm precisely the spatial location of the lipid-rich plaque due to lower resolution, signal attenuation did support this suggestion confirming a potential utility of IVUS in addition to NIRS. We also noted differences in the distribution of lipid within the stent detected on these two imaging modalities. While maximal lipid arcs were similar, NIRS demonstrated longer longitudinal extent of lipid. Like other reflectance-based light techniques, the signal detected by NIRS is dependent on illumination of the tissue and the detection of the reflected light, which in the case of NIRS is mostly collected from the first 1 mm of tissue cross-section from the catheter. 26, 27 This may result in signal attenuation or a lack of detection of lipid in thick-capped neoatheromas (fibrous cap thickness .1-2 mm), but should not cause issues for lipid detection in TCNAs that are the focus of the current study. Furthermore, depth information cannot be resolved on NIRS as there is no axial resolution and the NIRS signal is surface weighted. 26, 27 It may be feasible to account for the lack of axial (depth) resolution in NIRS by more careful analysis of the hybrid NIRS/IVUS images. Such analysis may clarify whether the signal for lipid originates from neointima (i.e. lipid on the luminal side of the stent or peri-struts) or from the lipid behind the stent struts.
We have previously described a classification of the distribution of neoatherosclerosis within the vascular wall using OCT, and this approach was undertaken with NIRS/IVUS in the recent report by Madder et al. 13 Interestingly, the neointimal patterns identified on IVUS closely correlated with the rates of stent failure in the followup period. Appropriately designed prospective studies are needed to determine whether the combination of our NIRS findings for the detection of TCNA with the patterns of NA on IVUS (to exclude deep-seated lipid behind stent) would result in better prediction of stent failure rates and whether changes in therapies as informed by NIRS/IVUS (e.g. intensified lipid lowering, prolonged dual-antiplatelet therapy) may decrease stent failure rates.
Study limitations
The sample size of this observational cohort is modest and includes patients undergoing elective PCI and thus may not be extrapolated to patients presenting with ACS. Our findings would benefit from external validation in a larger cohort of patients, ideally including patients presenting with ACS and patients with subclinical NA. The clinical utility of the LCBI thresholds we describe on NIRS in predicting plaque rupture within neoatheroscerotic tissue needs to be examined prospectively. NIRS lacks axial resolution and, despite complementary anatomical information provided by IVUS, may have limitations as a stand-alone modality to detect TCNA. Lastly, NIRS findings were compared with morphology of neointima on OCT and not histology. Although OCT is the gold standard to measure the thickness of the fibrous cap in vivo, further histological studies are needed to determine the accuracy of NIRS to detect TCNA. Fortunately these studies are underway. 28 
Conclusions
There is good agreement between NIRS and OCT to detect extent and distribution of lipid within neointimal tissue. With an LCBI density per 4 mm threshold of .144, NIRS is able to predict OCT-defined TCNA with high accuracy.
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